BENZONATATE
- Product NDC
- 51655-773
- 11-digit product format
- 516550773
- Labeler code
- 51655
- Product ID
- 51655-773_ec18e10d-91a1-4d20-8a6b-ddcc5ea9c44c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BENZONATATE
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- Northwind Pharmaceuticals
- Application
- ANDA040682
- Marketing category
- ANDA
- Marketing start
- 2015-03-12
- Marketing end
- 0000-00-00
- Substance
- BENZONATATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51655-773 | BENZONATATE CAPSULE, LIQUID FILLED [NORTHWIND PHARMACEUTICALS] | 2 | Legacy NDC | 20150507_b8b7c363-b87d-41e2-8145-7f8004c166db.zip |